Empagliflozin

Synopsis, Chemistry

APIs // Active Pharmaceutical Ingredients

97 API Suppliers, 35 USDMF, 10 EU WC, 31 KDMF, 20 NDC API, 79 Listed Suppliers

DEVELOPMENTS

50 Drug(s) in Development

50 Drug(s) in Development

PRICE INFORMATION

API Reference Price, API Exports, API Imports, FDF Imports

INTERMEDIATES

88 Suppliers

88 Suppliers

DOSSIERs // Finished Dosage Formulations

132 Dossiers, 50 FDA Orange Book, 30 Europe, 8 Canada, 6 Australia, 8 South Africa, 30 Listed Dossiers

DRUG PRODUCT COMPOSITION

TABLET;ORAL - 10MG, TABLET;ORAL - 25MG, TABLET;ORAL - 10MG;5MG, TABLET;ORAL - 25MG;5MG

TABLET;ORAL - 10MG
TABLET;ORAL - 25MG
TABLET;ORAL - 10MG;5MG
TABLET;ORAL - 25MG;5MG

GLOBAL SALES INFORMATION

8 US Medicaid Prescriptions, 30 Finished Drug Prices

MARKET PLACE

40 APIs, 13 DOSSIERS // FDF, 1 Intermediates

PATENTS

316 US Patents, 24 US Exclusivities, 4 Health Canada Patents

ANALYTICAL SOLUTION(s)

13 Other Ref. Standards

13 Other Ref. Standards

DIGITAL CONTENT

10 Data Compilations & Company Tracker #PharmaFlow, 280 News, 1 Monthly Stock Recap #PipelineProspector

List of Suppliers

Full Screen View

Reset Filter

Price Info

Suanfarma

SuanFarma is present in all origins: Natural, Chemical & Biotechnological.

Contact Supplier

Spain

Virtual Booth

Digital Content

(2-Chloro-5-Iodophenyl)(4-Fluorophenyl)Methanone

PDF Supplier PDF

URL Supplier Web Content

CAS Number

915095-86-2

End Use API

Suanfarma founded in 1993, is a B2B life science partner committed to health & innovation by developing, ...

Suanfarma founded in 1993, is a B2B life science partner committed to health & innovation by developing, manufacturing, & distributing high-quality APIs for the pharmaceutical industry innovatively & sustainably. Backed by a robust global network of 12 strategically located local offices, we cater to the needs of over 400 active customers in 70+ countries. At Suanfarma we offer our CDMO capacity for fermentation & chemical synthesis projects, offering a One Stop Shop service with a solid track record, & which allows us to achieve success in the development, scaling, manufacturing, & commercialization of an API, either innovative or generic.